Авторы

  • Salomov M.S., Xursandova Sh.Sh.
  • Yuldashev R.R.

Ключевые слова:

ko‘krak bezi, saraton, yoshlarda saraton

Библиографические ссылки

A.N. Giaquinto, H. Sung, L.A. Newman, et al. Breast cancer statistics 2024 CA Cancer J Clin, 74 (6) (2024), pp. 477-495

S. Xu, S. Murtagh, Y. Han, F. Wan, A.T. Toriola Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status JAMA Netw Open, 7 (1) (2024 Jan 2), Article e2353331

L. Barclay, E. Burn, A. Delmestri, T. Duarte-Salles, A. Golozar, W.Y. Man, E.H. Tan, I. Tietzova, Consortium Optima, D. Prieto-Alhambra, D. Newby Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 Sci Rep, 14 (1) (2024 Aug 17), Article 1906

R. Delis, E. Demuru, P. Baili, X. Troussard, A. Katalinic, M.D. Chirlaque Lopez, K. Innos, M. Santaquilani, M. Blum, L. Ventura, K. Paapsi, R. Galasso, M. Guevara, G. Randi, M. Bettio, L. Botta, S. Guzzinati, L. Dal Maso, S. Rossi, EUROCARE-6 Working Group Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study Lancet Oncol, 25 (3) (2024 Mar), pp. 293-307

Bénédicte LapôtreLedoux, Laurent Remontet, Zoé Uhry, Emmanuelle Dantony, Pascale Grosclaude, Florence Molinié, Anne-Sophie Woronoff, Camille Lecoffre-Bernard, Lionel Lafay, Gautier Defossez, Tania D'Almeida et le Réseau français des registres de cancers Francim Incidence des principaux cancers en France métropolitaine en 2023 et tendances depuis 1990 Bulletin Epidémiologique Hebdomadaire, 12–13 (2023), pp. 188-204

Z. Uhry, E. Chatignoux, E. Dantony, M. Colonna, L. Roche, M. Fauvernier, et al. Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates Int J Epidemiol, 49 (4) (2020), pp. 1294-1306

R. Doll, P. Payne, J.A. Waterhouse Cancer incidence in five continents: a technical report Springer-Verlag, New York (1966), p. 244

https://acsjournals.onlinelibrary. wiley.com/doi/full/10.3322/caac.21863#caac21863-bib-0062

K. Hemminki, A. Försti Incidence, mortality and survival trends in breast cancers coincident with introduction of mammography in the nordic countries Cancers, 14 (2022), p. 5907

R.M. Pfeiffer, Y. Webb-Vargas, W. Wheeler, M.H. Gail Proportion of U.S. trends in breast cancer incidence attributable to long-term changes in risk factor distributions Cancer Epidemiol Biomarkers Prev, 27 (10) (2018), pp. 1214-1222

B.E. Hamilton, J.A. Martin, M.J.K. Osterman Births: provisional data for 2023. Vital statistics rapid release, no. 35. NCHS vital statistics rapid release reports National Center for Health Statistics (2024)

A. Morra, A.Y. Jung, S. Behrens, et al. Breast cancer risk factors and survival by tumor subtype: pooled analyses from the breast cancer association consortium Cancer Epidemiol Biomarkers Prev, 30 (4) (2021), pp. 62 3-642

P. Pujol, S.G. Hilsenbeck, G.C. Chamness, R.M. Elledge Rising levels of estrogen receptor in breast cancer over 2 decades Cancer, 74 (5) (1994 Sep 1), pp. 1601-1606

US Preventive Services Task Force Screening for breast cancer: US preventive services task force recommendation statement JAMA, 331 (22) (2024), p. 1973

European guidelines on breast cancer screening and diagnosis https://cancer-screening-and-care.jrc.ec.europa.eu/en/ecibc /european-breast-cancer-guidelines?topic=6 3&usertype=60&updatef2=0